Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
Autor: | Serkland TT; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway., Skrede S; Haukeland University Hospital, University of Bergen, Bergen, Norway., Berg JA; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway. |
---|---|
Jazyk: | angličtina |
Zdroj: | JAMA [JAMA] 2021 Sep 21; Vol. 326 (11), pp. 1068-1069. |
DOI: | 10.1001/jama.2021.11471 |
Databáze: | MEDLINE |
Externí odkaz: |